scispace - formally typeset
S

Santosha Vardhana

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  24
Citations -  1422

Santosha Vardhana is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: T cell & Immune system. The author has an hindex of 10, co-authored 24 publications receiving 681 citations.

Papers
More filters
Journal ArticleDOI

The many faces of the anti-COVID immune response.

TL;DR: This Perspective explores the contributions of the innate and adaptive immune systems to both viral control as well as toxicity during COVID-19 infections and offers suggestions to both understand and therapeutically modulate anti-COVID immunity.
Journal ArticleDOI

CD8 + T cells contribute to survival in patients with COVID-19 and hematologic cancer.

TL;DR: In this paper, the authors showed that CD8 T cell responses to vaccination might provide protection in patients with hematologic cancer even in the setting of limited humoral responses, including those treated with anti-CD20 therapy.
Journal ArticleDOI

Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen.

TL;DR: It is revealed that loss of ATP production through oxidative phosphorylation limits T cell proliferation and effector function during chronic antigenic stimulation, and treatments that maintain redox balance promote T cell self-renewal and enhance anti-tumor immunity.
Journal ArticleDOI

Cancer Metabolism Drives a Stromal Regenerative Response.

TL;DR: It is proposed that metabolites consumed and released by tumor cells act as paracrine factors that regulate the non-malignant cellular composition of a developing tumor by driving stromal cells toward a regenerative response that supports tumor growth.
Journal ArticleDOI

The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints.

TL;DR: This review summarizes what is known regarding T cells, B cells, and immune checkpoints in classical Hodgkin lymphoma to help clarify the role of the immune microenvironment in either promoting or restricting Classical Hodgkins lymphoma growth.